In the realm of science fiction, mind-reading capabilities have often been the domain of superheroes and wizards. However, advancing neurotechnology is hinting at a future where deciphering thoughts is not just a hypothetical scenario. As these technologies develop, they raise significant privacy concerns that regulators will soon need to address. Companies working in this sector should now look to establish industry standards and best practices to frame future legislation.
Neurotechnology ranges from non-invasive, electroencephalogram headbands used for recreational purposes like improving your golf game, to invasive brain implants used in conjunction with artificial intelligence to aid ALS patients in regaining their speech. This technology also has broader implications for research, where it has been used to determine previously unknowable information, such as the image individuals are viewing from a large database or predicting an individual’s choice 11 seconds before they are even consciously aware of making the decision.
Significant corporate investment is seeing the expansion and adoption of these innovations. High-profile examples include Elon Musk’s Neuralink Corp., which has recently gained approval from the FDA for human trials, and Meta’s teased “brain-machine interface” wristband. Through brain waves, electrical nerve impulses, and the recognition of brain activity during certain thoughts or actions, these technologies generate unique neurodata.
This neurodata can create a “brain fingerprint” by measuring brainwaves through EEG to identify individuals in contexts such as criminal investigations. It also provides insights into an individual’s thoughts, memories, emotions, biases, attention span, preferences, and intentions, opening the possibility for an unprecedented level of intrusion into mental privacy.
On a legislative level, Chile is currently the only country with laws directly addressing neurorights, where scientific and technological developments must protect brain activity and the information collected from it. In the US, neither the federal government nor the states have enacted laws that directly apply privacy principles to neurodata; however, existing laws cover certain categories, albeit in a limited scope.
The companies driving these technological advancements should take proactive measures now to develop industry standards and best practices for the handling and use of neurodata. This approach offers a practical and effective framework that can guide and shape future legislation. Adopting transparency in privacy policies, ensuring informed consent, and implementing robust safeguards for neurodata protection should be at the heart of these efforts.
Looking towards the future, despite the privacy implications and challenges, neurotechnology and neurodata promise to bring unprecedented advancements, benefiting society in many ways. The vital first steps in ensuring neuroprivacy will set the stage for these innovations to flourish responsibly and ethically.
For more detailed insights, visit the full report on neurotechnology and its impact on privacy and regulations at bloomberglaw.com.